Page last updated: 2024-08-22

triamcinolone hexacetonide and Bone Loss, Osteoclastic

triamcinolone hexacetonide has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Volkmann, A; Wilckens, T	1

Other Studies

1 other study(ies) available for triamcinolone hexacetonide and Bone Loss, Osteoclastic

Article	Year
Cortisol metabolism by 11 beta-hydroxysteroid dehydrogenase as a novel target in the treatment of inflammation- or immune-mediated bone loss: comment on the article by Makrygiannakis et al. Arthritis and rheumatism, 2007, Volume: 56, Issue:1 Topics: 11-beta-Hydroxysteroid Dehydrogenases; Anti-Inflammatory Agents; Arthritis; Bone Resorption; Down-Regulation; Humans; Hydrocortisone; Inflammation; Injections, Intra-Articular; Triamcinolone Acetonide	2007

Article

Year

Cortisol metabolism by 11 beta-hydroxysteroid dehydrogenase as a novel target in the treatment of inflammation- or immune-mediated bone loss: comment on the article by Makrygiannakis et al.

Arthritis and rheumatism, 2007, Volume: 56, Issue:1

Topics: 11-beta-Hydroxysteroid Dehydrogenases; Anti-Inflammatory Agents; Arthritis; Bone Resorption; Down-Regulation; Humans; Hydrocortisone; Inflammation; Injections, Intra-Articular; Triamcinolone Acetonide

2007